The PM CARES Fund Trust has allocated Rs 3,100 crore to purchase ‘Made in India’ ventilators, vaccine programmes, and for supporting migrant workers, among others.

Out of the Rs 3,100 crore, nearly Rs 2,000 crore will be allocated for the purchase of ventilators and Rs 1,000 crore for care of migrant labourers, the Prime Minister’s Office said. Rs 100 crore will be given to support coronavirus vaccine development efforts, a PMO statement was quoted saying by PTI report.

Prime Minister Narendra Modi had announced creation of the PM’s Citizen Assistance and Relief in Emergency Situations Fund (PM-CARES) where people of every walk of lives could contribute to help the government to tackle the pandemic and other such emergency situations.

Headed by the prime minister, the trust was formed on March 27. The other ex-officio members of the trust are the defence minister, the home minister and the finance minister.

For augmenting the infrastructure to tackle Covid-19 cases across the country, 50,000 ‘Made-in-India’ ventilators will be purchased from PM CARES Fund at a cost of approximately Rs 2000 crore, the statement said.

These ventilators will be provided to government-run Covid hospitals in all states and union territories for better treatment of the critical Covid-19 cases, it added.

Several institutions of higher learning and defence establishments have pitched in to produce low-cost ventilators after the outbreak of the virus.

For strengthening the existing measures being taken for the welfare of the migrants and the poor, states and UTs will be given a lump sum assistance totalling Rs 1,000 crore from the fund.

The amount would be provided to state governments and UTs for district collectors or municipal commissioners to strengthen efforts to provide accommodation, food, medical treatment and transportation to the migrants, the statement explained.

Like

Dislike

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.